Nelfinavir - Agouron Pharmaceuticals/Japan Tobacco
Alternative Names: AG 1343; LY 312857; Nelfinavir mesylate; ViraceptLatest Information Update: 24 Oct 2021
At a glance
- Originator Agouron Pharmaceuticals; Japan Tobacco
- Developer Agouron Pharmaceuticals; Chugai Pharmaceutical; Japan Tobacco
- Class Antiretrovirals; Isoquinolines
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed HIV infections
Most Recent Events
- 02 Dec 2011 Withdrawn for HIV infections in Switzerland (PO)
- 01 Dec 2011 Withdrawn for HIV infections in European Union (PO)
- 19 Oct 2007 The European Commission has re-instated the marketing authorisation for nelfinavir